These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 21266668

  • 21. Soluble epoxide hydrolase: a new target for cardioprotection.
    Gross GJ, Nithipatikom K.
    Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat.
    Corenblum MJ, Wise VE, Georgi K, Hammock BD, Doris PA, Fornage M.
    Hypertension; 2008 Feb; 51(2):567-73. PubMed ID: 18086949
    [Abstract] [Full Text] [Related]

  • 24. Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.
    Revermann M, Schloss M, Barbosa-Sicard E, Mieth A, Liebner S, Morisseau C, Geisslinger G, Schermuly RT, Fleming I, Hammock BD, Brandes RP.
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):909-14. PubMed ID: 20224052
    [Abstract] [Full Text] [Related]

  • 25. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
    Nayeem MA, Pradhan I, Mustafa SJ, Morisseau C, Falck JR, Zeldin DC.
    Am J Physiol Regul Integr Comp Physiol; 2013 Jan 01; 304(1):R23-32. PubMed ID: 23152114
    [Abstract] [Full Text] [Related]

  • 26. Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney.
    Lee JP, Yang SH, Lee HY, Kim B, Cho JY, Paik JH, Oh YJ, Kim DK, Lim CS, Kim YS.
    PLoS One; 2012 Jan 01; 7(5):e37075. PubMed ID: 22590647
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Soluble Epoxide Hydrolase Inhibitor Ameliorates Olfactory Dysfunction, Modulates Microglia Polarization, and Attenuates Neuroinflammation after Ischemic Brain Injury.
    Yeh CF, Chuang TY, Lan MY, Lin YY, Huang WH, Hung YW.
    J Neuroimmune Pharmacol; 2024 Oct 17; 19(1):54. PubMed ID: 39417923
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A, Merkel MJ, Packwood WH, Cao Z, Liu L, Iliff J, Alkayed NJ, Van Winkle DM.
    Am J Physiol Heart Circ Physiol; 2008 Nov 17; 295(5):H2128-34. PubMed ID: 18835921
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure.
    Merabet N, Bellien J, Glevarec E, Nicol L, Lucas D, Remy-Jouet I, Bounoure F, Dreano Y, Wecker D, Thuillez C, Mulder P.
    J Mol Cell Cardiol; 2012 Mar 17; 52(3):660-6. PubMed ID: 22155238
    [Abstract] [Full Text] [Related]

  • 33. Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.
    Sporková A, Jíchová S, Husková Z, Kopkan L, Nishiyama A, Hwang SH, Hammock BD, Imig JD, Kompanowska-Jezierska E, Sadowski J, Kramer HJ, Cervenka L.
    Clin Exp Pharmacol Physiol; 2014 Dec 17; 41(12):1003-13. PubMed ID: 25224811
    [Abstract] [Full Text] [Related]

  • 34. Soluble Epoxide Hydrolase Inhibition Attenuates Proteinuria by Alleviating Renal Inflammation and Podocyte Injuries in Adriamycin-Induced Nephropathy.
    Niu Q, Guo Z, Liang Y, Zuo L.
    Int J Mol Sci; 2024 Oct 02; 25(19):. PubMed ID: 39408958
    [Abstract] [Full Text] [Related]

  • 35. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
    Zhang W, Koerner IP, Noppens R, Grafe M, Tsai HJ, Morisseau C, Luria A, Hammock BD, Falck JR, Alkayed NJ.
    J Cereb Blood Flow Metab; 2007 Dec 02; 27(12):1931-40. PubMed ID: 17440491
    [Abstract] [Full Text] [Related]

  • 36. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
    Li L, Li N, Pang W, Zhang X, Hammock BD, Ai D, Zhu Y.
    PLoS One; 2014 Dec 02; 9(4):e94092. PubMed ID: 24718617
    [Abstract] [Full Text] [Related]

  • 37. Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts.
    Bannehr M, Löhr L, Gelep J, Haverkamp W, Schunck WH, Gollasch M, Wutzler A.
    Cardiovasc Toxicol; 2019 Aug 02; 19(4):365-371. PubMed ID: 30725262
    [Abstract] [Full Text] [Related]

  • 38. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
    Katary MM, Pye C, Elmarakby AA.
    Prostaglandins Other Lipid Mediat; 2017 Sep 02; 132():3-11. PubMed ID: 27596333
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of soluble epoxide hydrolase regulates monocyte/macrophage polarization and improves neurological outcome in a rat model of ischemic stroke.
    Yeh CF, Chuang TY, Hung YW, Lan MY, Tsai CH, Huang HX, Lin YY.
    Neuroreport; 2019 May 22; 30(8):567-572. PubMed ID: 30950936
    [Abstract] [Full Text] [Related]

  • 40. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
    Wu CH, Shyue SK, Hung TH, Wen S, Lin CC, Chang CF, Chen SF.
    J Neuroinflammation; 2017 Nov 25; 14(1):230. PubMed ID: 29178914
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.